BACKGROUND: Stress hyperglycemia refers to the transient hyperglycemia seen during illness and is usually restricted to patients without previous evidence of diabetes. The influence of genetics on surgery-induced hyperglycemia remains only partially understood. METHODS: The study participants were Japanese patients treated for thoracic esophageal cancer with curative esophagectomy at Akita University Hospital between 2003 and 2007. We determined the associations between esophagectomy-induced stress hyperglycemia (> or =30 mg/dl increases in blood glucose during surgery) and genetic polymorphisms for C-reactive protein (CRP), tumor necrosis factor (TNF)-alpha, -beta, interferon-gamma, transforming growth factor-beta1, interleukin (IL)-1beta, IL-2, IL-4, IL-6, IL-6 receptors, IL-10, IL-12beta, adiponectin, and peroxisome proliferator-activated receptor-gamma. RESULTS: In 28 (46%) patients, blood glucose levels increased more than 30 mg/dl during surgery. Among the genetic polymorphisms tested, CRP -717C>T was significantly associated with stress hyperglycemia during esophagectomy. Multivariate logistic regression revealed that patients with the CRP -717T/T genotype had a significantly greater risk of developing surgery-induced hyperglycemia than those with the CRP -717C/T genotype. Stress hyperglycemia was also significantly associated with postoperative infectious complications and duration of intensive care unit stay. CONCLUSIONS: It is suggested that CRP -717 C>T genetic polymorphism may be a predictive factor for stress hyperglycemia in patients receiving esophagectomy for thoracic esophageal cancer.
BACKGROUND:Stress hyperglycemia refers to the transient hyperglycemia seen during illness and is usually restricted to patients without previous evidence of diabetes. The influence of genetics on surgery-induced hyperglycemia remains only partially understood. METHODS: The study participants were Japanese patients treated for thoracic esophageal cancer with curative esophagectomy at Akita University Hospital between 2003 and 2007. We determined the associations between esophagectomy-induced stress hyperglycemia (> or =30 mg/dl increases in blood glucose during surgery) and genetic polymorphisms for C-reactive protein (CRP), tumor necrosis factor (TNF)-alpha, -beta, interferon-gamma, transforming growth factor-beta1, interleukin (IL)-1beta, IL-2, IL-4, IL-6, IL-6 receptors, IL-10, IL-12beta, adiponectin, and peroxisome proliferator-activated receptor-gamma. RESULTS: In 28 (46%) patients, blood glucose levels increased more than 30 mg/dl during surgery. Among the genetic polymorphisms tested, CRP -717C>T was significantly associated with stress hyperglycemia during esophagectomy. Multivariate logistic regression revealed that patients with the CRP -717T/T genotype had a significantly greater risk of developing surgery-induced hyperglycemia than those with the CRP-717C/T genotype. Stress hyperglycemia was also significantly associated with postoperative infectious complications and duration of intensive care unit stay. CONCLUSIONS: It is suggested that CRP -717 C>T genetic polymorphism may be a predictive factor for stress hyperglycemia in patients receiving esophagectomy for thoracic esophageal cancer.
Authors: Owen A Ross; Martin D Curran; Ashley Meenagh; Fionnuala Williams; Yvonne A Barnett; Derek Middleton; I Maeve Rea Journal: Mech Ageing Dev Date: 2003-02 Impact factor: 5.432
Authors: T Kanemaki; H Kitade; M Kaibori; K Sakitani; Y Hiramatsu; Y Kamiyama; S Ito; T Okumura Journal: Hepatology Date: 1998-05 Impact factor: 17.425
Authors: C Eklund; M Kivimäki; Md Shaheenul Islam; M Juonala; M Kähönen; J Marniemi; T Lehtimäki; J Viikari; O T Raitakari; M Hurme Journal: Atherosclerosis Date: 2007-03-09 Impact factor: 5.162
Authors: Terho Lehtimäki; Reijo Laaksonen; Tuula Janatuinen; Risto Vesalainen; Pirjo Nuutila; Kari Mattila; Erkki Ilveskoski; Mari Luomala; Pekka Saikku; Juhani Knuuti; Mikko Hurme Journal: Pharmacogenetics Date: 2003-10
Authors: Gunjan Y Gandhi; M Hassan Murad; David N Flynn; Patricia J Erwin; Alexandre B Cavalcante; Henning Bay Nielsen; Sarah E Capes; Kristian Thorlund; Victor M Montori; P J Devereaux Journal: Mayo Clin Proc Date: 2008-04 Impact factor: 7.616
Authors: Joseph G Yu; Sandrine Javorschi; Andrea L Hevener; Yolanta T Kruszynska; Rodney A Norman; Madhur Sinha; Jerrold M Olefsky Journal: Diabetes Date: 2002-10 Impact factor: 9.461
Authors: Sumanta Dutta; Grant M Fullarton; Matthew J Forshaw; Paul G Horgan; Donald C McMillan Journal: World J Surg Date: 2011-05 Impact factor: 3.352
Authors: Peter McAnena; Colm Neary; Conor Doyle; Michael J Kerin; Oliver J McAnena; Chris Collins Journal: Ir J Med Sci Date: 2019-08-01 Impact factor: 1.568
Authors: Joseph Beecham; Andrew Hart; Leo Alexandre; James Hernon; Bhaskar Kumar; Stephen Lam Journal: J Gastrointest Surg Date: 2019-07-03 Impact factor: 3.452